Our brands

HERTAB

HERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose disease has progressed after taking Trastuzumab therapy.

HERTAB

subscribe

Keep yourself updated with our new product information and much more.

Copyright © All Rights Reserved by Hetero Healthcare Limited